CB
EW icon

Centennial Bank’s Edwards Lifesciences EW Stock Holding History

Centennial Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-180
Closed -$16.6K – 326
2024
Q2 		$16.6K Hold
180
– – 0.01% 243
2024
Q1 		$17.2K Hold
180
– – 0.01% 237
2023
Q4 		$13.7K Buy
180
+120
+200% +$8.35K 0.01% 252
2023
Q3 		$4.16K Sell
60
-51
-46% -$4.1K ﹤0.01% 295
2023
Q2 		$10.5K Sell
111
-106
-49% -$9.21K 0.01% 263
2023
Q1 		$11.7K Buy
217
+106
+95% +$8.33K 0.01% 257
2022
Q4 		$8.28K Buy
+111
New +$8.55K ﹤0.01% 289

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Centennial Bank's EW Position: Q3 2024 in Review

Centennial Bank sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 180 shares — an estimated $16.6K sold.

Centennial Bank first reported a position in EW in Q4 2022 and held it in 7 quarters. The position peaked at $17.2K in Q1 2024. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Centennial Bank reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Centennial Bank sold 180 Edwards Lifesciences shares in Q3 2024, an estimated $16.6K.
  • Centennial Bank first reported a position in Edwards Lifesciences in Q4 2022 and held it in 7 quarters.
  • Centennial Bank's Edwards Lifesciences position peaked at $17.2K in Q1 2024.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Centennial Bank's 13F filing for Q3 2024, filed 29 Oct 2024.